Campion EW,deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: Report from the Normative Aging Study. J Gerontol. 1988;43:M18-M20.
Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatric Med. 1990; 6:269-283.
Greenblatt DJ, Sellers EM, Koch-Weser J. Importance of protein binding for the interpretation of serum or plama drug concentrations. J Clin Pharmacol. 1982;22:259-263.
Hammarlund ER, Ostrom JR, Kethley AJ. The effects of drug counseling and other educational strategies on drug utilization in the elderly. Med Care. 1985;23:165-170.
Hanlon JT, Schmader KE, Koronkowski Mj, et al. Adverse drug events in high risk older patients. J Am Geriatr Soc. 1997; 45(8):945-8.
Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-year-old men and women. J Appl Physiol. 1991;71:644-650.
Lamy PP. Physiological changes due to age: pharmacodynamic changes of drug action and implications of therapy. Drugs Aging. 1991;1:385-404.
Levy RA. Therapeutic inequivalence of pharmaceutical alternates. Amer Pharm. 1985; April: 28-39.
MacLennan WJ, Martin P, Mason BJ. Protein intake and serum albumin levels in the elderly. Gerontology. 1977;23:360-367.
Schmucker DL. Aging and drug disposition: An update. Pharmacol Rev. 1985;37:133-148.
Thoreson J. Drug Metabolism and Drug/Drug Interactions from a Geriatrics Perspective. Clin Ger. 1997; 5: 57-74.
Tregaskis BF, Stevenson IH. Pharmacokinetics in old age. Br Med Bulletin. 1990; 46: 9-21.
Wilcox SM, Himmelstein, Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994; 272:292-296